Corrigendum to 'Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study': [The American Journal of Medicine (2022) Volume 136(12), 1461-1467]
Am J Med. 2023 Mar;136(3):329.
doi: 10.1016/j.amjmed.2022.11.004.
Epub 2022 Dec 6.
1 Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, MD. Electronic address: jechouf1@jhmi.edu.
2 Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
3 Division of Cardiology and National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland.
4 Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
5 Section of Cardiovascular Research, Baylor College of Medicine & Houston Methodist DeBakey Heart and Vascular Center, Houston, TX.